Iterum Therapeutics plc insider trading activity

Understanding Insider Activity at Iterum Therapeutics plc

Welcome to our dedicated page for Iterum Therapeutics plc (Nasdaq: ITRM) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Iterum Therapeutics plc's key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Iterum Therapeutics plc, and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for ITRM
TickerTime & DateFilingLink
ITRM2:00:06 PM, 12/27/2023
Dunne Michael W. purchased 25000 shares of Iterum Therapeutics plc (ITRM) for ~$35000
Filing
ITRM9:15:25 PM, 12/19/2023
Dunne Michael W. purchased 10000 shares of Iterum Therapeutics plc (ITRM) for ~$18400
Filing
ITRM10:00:19 PM, 11/27/2023
Dunne Michael W. purchased 20000 shares of Iterum Therapeutics plc (ITRM) for ~$40599
Filing
ITRM10:00:22 PM, 11/20/2023
Fishman Corey N.(Chief Executive Officer) purchased 10000 shares of Iterum Therapeutics plc (ITRM) for ~$15900
Filing
ITRM10:00:33 PM 12/5/2022
Puttagunta Sailaja(Chief Medical Officer) sold 3365 shares of Iterum Therapeutics plc (ITRM) for ~$4441
Filing